NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/22/2024
Back to search
Official data from USPTO
NALDEBAIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
9
Latest update
10/22/2024
Trademark type
Combined
Nice classes
5
Filing date
11/02/2023
Registration date
10/22/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/22/2024
Last transaction
10/22/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
TAIPEI CITY, TW
Examiner
SINGER, MELANIE
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "NALDEBAIN".
Holders and representatives
Holders
LUMOSA THERAPEUTICS CO., LTD.
Representatives
HUI ZHANG RABIN & BERDO, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pain relief medication
Publications
History of USPTO decisions and trademark events.
9 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2024
PUBO
PUBLISHED FOR OPPOSITION
08/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/27/2024
DOCK
ASSIGNED TO EXAMINER
06/13/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/20/2023
NWAP
NEW APPLICATION ENTERED
11/06/2023
Continuous trademark protection
Get notified about every new filing that threatens NALDEBAIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.